Glen Santangelo
Stock Analyst at Barclays
(3.18)
# 1,099
Out of 5,148 analysts
127
Total ratings
50%
Success rate
0.95%
Average return
Main Sectors:
Stocks Rated by Glen Santangelo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALGN Align Technology | Maintains: Equal-Weight | $170 → $200 | $189.02 | +5.81% | 3 | Feb 26, 2026 | |
| HIMS Hims & Hers Health | Maintains: Overweight | $48 → $25 | $16.48 | +51.70% | 6 | Feb 25, 2026 | |
| BHC Bausch Health Companies | Maintains: Equal-Weight | $8 → $7 | $5.95 | +17.65% | 2 | Feb 25, 2026 | |
| OGN Organon & Co. | Maintains: Underweight | $7.5 → $8 | $7.19 | +11.27% | 2 | Feb 24, 2026 | |
| CAH Cardinal Health | Maintains: Overweight | $243 → $258 | $229.88 | +12.23% | 6 | Feb 24, 2026 | |
| MCK McKesson | Maintains: Overweight | $960 → $1,050 | $990.95 | +5.96% | 7 | Feb 18, 2026 | |
| HQY HealthEquity | Maintains: Overweight | $118 → $110 | $77.93 | +41.15% | 8 | Feb 18, 2026 | |
| COR Cencora | Maintains: Overweight | $400 → $425 | $372.65 | +14.05% | 2 | Feb 13, 2026 | |
| NVST Envista Holdings | Maintains: Overweight | $24 → $34 | $29.44 | +15.49% | 3 | Feb 11, 2026 | |
| DOCS Doximity | Maintains: Overweight | $63 → $38 | $25.70 | +47.86% | 4 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $850 → $800 | $636.70 | +25.65% | 2 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $35 → $38 | $33.77 | +12.53% | 7 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $5.25 → $2.75 | $2.17 | +26.73% | 3 | Jan 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $50 | $45.85 | +9.05% | 1 | Jan 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $56 | $41.60 | +34.62% | 5 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 → $24 | $12.27 | +95.60% | 3 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $136 | $128.96 | +5.46% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $6.02 | +49.50% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $15 | $15.70 | -4.46% | 5 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $8.5 | $5.16 | +64.73% | 8 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $100 | $77.43 | +29.15% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $3.5 | $4.93 | -29.01% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $29 | $17.60 | +64.77% | 5 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $16 | $11.46 | +39.62% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $27 | $21.25 | +27.06% | 6 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $86 | $81.37 | +5.69% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $26.09 | +14.99% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $12 | $14.31 | -16.14% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $100 | $75.22 | +32.94% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $30 | $21.01 | +42.79% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $15 | $13.77 | +8.93% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $49 | $37.89 | +29.32% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $5 | $3.96 | +26.26% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $51 | $26.25 | +94.29% | 1 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $5.37 | +1,762.20% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $55 | $89.25 | -38.38% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $31 → $28 | $1.68 | +1,566.67% | 2 | Mar 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $120 | $5.30 | +2,164.15% | 3 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $1.14 | +3,057.89% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $81.66 | - | 3 | Mar 17, 2021 |
Align Technology
Feb 26, 2026
Maintains: Equal-Weight
Price Target: $170 → $200
Current: $189.02
Upside: +5.81%
Hims & Hers Health
Feb 25, 2026
Maintains: Overweight
Price Target: $48 → $25
Current: $16.48
Upside: +51.70%
Bausch Health Companies
Feb 25, 2026
Maintains: Equal-Weight
Price Target: $8 → $7
Current: $5.95
Upside: +17.65%
Organon & Co.
Feb 24, 2026
Maintains: Underweight
Price Target: $7.5 → $8
Current: $7.19
Upside: +11.27%
Cardinal Health
Feb 24, 2026
Maintains: Overweight
Price Target: $243 → $258
Current: $229.88
Upside: +12.23%
McKesson
Feb 18, 2026
Maintains: Overweight
Price Target: $960 → $1,050
Current: $990.95
Upside: +5.96%
HealthEquity
Feb 18, 2026
Maintains: Overweight
Price Target: $118 → $110
Current: $77.93
Upside: +41.15%
Cencora
Feb 13, 2026
Maintains: Overweight
Price Target: $400 → $425
Current: $372.65
Upside: +14.05%
Envista Holdings
Feb 11, 2026
Maintains: Overweight
Price Target: $24 → $34
Current: $29.44
Upside: +15.49%
Doximity
Feb 11, 2026
Maintains: Overweight
Price Target: $63 → $38
Current: $25.70
Upside: +47.86%
Feb 5, 2026
Maintains: Overweight
Price Target: $850 → $800
Current: $636.70
Upside: +25.65%
Jan 30, 2026
Maintains: Overweight
Price Target: $35 → $38
Current: $33.77
Upside: +12.53%
Jan 22, 2026
Downgrades: Hold
Price Target: $5.25 → $2.75
Current: $2.17
Upside: +26.73%
Jan 12, 2026
Initiates: Overweight
Price Target: $50
Current: $45.85
Upside: +9.05%
Jan 9, 2026
Maintains: Overweight
Price Target: $58 → $56
Current: $41.60
Upside: +34.62%
Dec 16, 2025
Maintains: Overweight
Price Target: $26 → $24
Current: $12.27
Upside: +95.60%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $136
Current: $128.96
Upside: +5.46%
Dec 9, 2025
Initiates: Overweight
Price Target: $9
Current: $6.02
Upside: +49.50%
Dec 9, 2025
Initiates: Overweight
Price Target: $15
Current: $15.70
Upside: -4.46%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $8.5
Current: $5.16
Upside: +64.73%
Dec 9, 2025
Initiates: Overweight
Price Target: $100
Current: $77.43
Upside: +29.15%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $3.5
Current: $4.93
Upside: -29.01%
Dec 9, 2025
Initiates: Overweight
Price Target: $29
Current: $17.60
Upside: +64.77%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $16
Current: $11.46
Upside: +39.62%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $27
Current: $21.25
Upside: +27.06%
Dec 9, 2025
Initiates: Overweight
Price Target: $86
Current: $81.37
Upside: +5.69%
Dec 9, 2025
Initiates: Overweight
Price Target: $30
Current: $26.09
Upside: +14.99%
Dec 9, 2025
Initiates: Underweight
Price Target: $12
Current: $14.31
Upside: -16.14%
Dec 9, 2025
Initiates: Overweight
Price Target: $100
Current: $75.22
Upside: +32.94%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $30
Current: $21.01
Upside: +42.79%
Dec 9, 2025
Initiates: Overweight
Price Target: $15
Current: $13.77
Upside: +8.93%
Dec 9, 2025
Initiates: Overweight
Price Target: $49
Current: $37.89
Upside: +29.32%
Dec 9, 2025
Initiates: Underweight
Price Target: $5
Current: $3.96
Upside: +26.26%
Feb 11, 2025
Initiates: Buy
Price Target: $51
Current: $26.25
Upside: +94.29%
Dec 15, 2023
Reiterates: Buy
Price Target: $100
Current: $5.37
Upside: +1,762.20%
Oct 21, 2022
Initiates: Hold
Price Target: $55
Current: $89.25
Upside: -38.38%
Mar 17, 2022
Upgrades: Buy
Price Target: $31 → $28
Current: $1.68
Upside: +1,566.67%
Dec 2, 2021
Initiates: Hold
Price Target: $120
Current: $5.30
Upside: +2,164.15%
Dec 2, 2021
Initiates: Buy
Price Target: $36
Current: $1.14
Upside: +3,057.89%
Mar 17, 2021
Downgrades: Neutral
Price Target: n/a
Current: $81.66
Upside: -